MOESM2 of Clinical evidence-guided network pharmacology analysis reveals a critical contribution of β1-adrenoreceptor upregulation to bradycardia alleviation by Shenxian-Shengmai

Additional file 2: Table S2. Characteristics of meta-analysis studies, including patient groups; diagnosis criteria of bradycardia; mode of administration and course of treatment; selection of drugs in the control group; evaluation indicators and adverse effects.